Ihor R. Lemischka

Last updated
Ihor R. Lemischka (2nd from right) in San Diego CMS HBS IL KM.jpeg
Ihor R. Lemischka (2nd from right) in San Diego

Ihor R. Lemischka was an American stem cell biologist and stem cell research advocate [1] and was both the Lillian and Henry M. Stratton Professor of Gene and Cell Medicine and Director of the Black Family Stem Cell Institute at Mount Sinai Medical Center in New York City. [2]

Contents

His work with hematopoietic stem cells (HSC) was the first to identify their novel receptor tyrosine kinases and showed that HSC can rebuild all blood cell types in a mouse whose blood cells had been destroyed. [3] [4]

He authored over 70 book chapters and publications in peer-reviewed journals. [5]

Biography

Education and post-doctoral training

Lemischka graduated from Johns Hopkins University in 1976 [6] and earned his Ph.D. in biology from MIT in 1983. He did his post-doctoral training at MIT's Whitehead Institute.

Academic appointments

Lemischka joined Princeton University in 1986 as Assistant Professor of Molecular Biology; he became Professor in 2002. [5] In 2007, he joined the staff at Mount Sinai Medical Center, where he was Professor of Gene and Cell Medicine and Director of the Black Family Stem Cell Institute.

Affiliations and awards

Lemischka was a board member of the International Society for Stem Cell Research, the Journal of Visualized Experiments (JoVE) and the New York Stem Cell Foundation. His awards included a Damon Runyon-Walter Winchell Postdoctoral, a Leukemia Social Special Fellowship, an American Cyanamid Preceptorship Award and the DuPont Young Faculty Grant. [5] He was a journal reviewer for Cell, Science, Nature, Nature Genetics, Nature Immunology, Nature Biotechnology, Proceedings of the National Academy of Sciences, Public Library of Science, Development, Genes & Development, Journal of Clinical Investigation and Blood.

Patents

Lemischka held or had patents pending for the following: [7]

Patent NumberTitle
7465464Populations of cells that express flk-2 receptors
7445798Populations of cells that express FLK-1 receptors
6960446Method for isolating cells expressing flk-2
6677434Soluble human flk-2 protein
6613565Use of delta-like protein to inhibit the differentiation of stem cells
5912133Method for isolating stem cells expressing flk-1 receptors
5747651Antibodies against tyrosine kinase receptor flk-1
5621090Nucleic acids encoding soluble human FLK-2 extracellular domain
5548065Tyrosine kinase receptor human flk-2-specific antibodies
5367057Tyrosine kinase receptor flk-2 and fragments thereof
5283354Nucleic acids encoding hematopoietic stem cells receptors flk-1
5270458Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
5185438Nucleic acids encoding hencatoporetic stem cell receptor flk-2

Areas of concentration

Lemischka's interests included defining the cellular and molecular mechanisms that control cell fate decisions in embryonic stem cells. Research into mouse embryonic stem cells was aggressively studied in the embryonic stem cells of humans. [8]

Publications

Partial List:

References

  1. Monya Baker (October 8, 2009). "Ihor Lemischka: stem cells meet systems biology". Nature Reports. Nature: 1. doi:10.1038/stemcells.2009.129 . Retrieved December 22, 2009.
  2. "SciVee". Archived from the original on 2010-03-14. Retrieved 2009-12-22.
  3. Cass Cliatt (June 19, 2006). "Princeton scientists explore the next frontier of stem cell research". The Princeton Weekly Bulletin. Princeton University. Retrieved December 22, 2009.
  4. "Ihor Lemischka to deliver spring Dean's Lecture". Penn State Live. Penn State University. May 14, 2009. Archived from the original on February 22, 2012. Retrieved December 22, 2009.
  5. 1 2 3 Bioconnex.org
  6. Mount Sinai School of Medicine – Faculty profile
  7. "PatentGenius.com". Archived from the original on 2012-02-25. Retrieved 2009-12-22.
  8. "New York State Stem Cell Science". Archived from the original on 2010-01-07. Retrieved 2009-12-22.